The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

CNBC's Karen Gilchrist weighs in on Zealand Pharma's "next generation" obesity drug candidate and its search for a global ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Dr. Deepak Chopra warns against the brain-related risks of weight-loss drugs, emphasizing their potential to alter metabolism ...